Metoprolol effects on bradycardia
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol and Bradycardia: Heart Rate Reduction and Risk Factors
Metoprolol, a beta-blocker, is widely used to lower heart rate, but it can also cause bradycardia (a heart rate below 60 beats per minute). The risk and severity of bradycardia with metoprolol use depend on several factors, including sex, genetics, drug interactions, and underlying health conditions.
Sex-Based Differences in Metoprolol-Induced Bradycardia
Research shows that women are more sensitive to metoprolol’s heart rate-lowering effects than men. Higher plasma concentrations of metoprolol in women are linked to a significantly greater reduction in heart rate and a much higher risk of bradycardia compared to men, even after adjusting for other health factors. In women, those with the highest metoprolol levels had over 15 times the risk of bradycardia compared to those with the lowest levels, a pattern not seen in men.
Genetic Factors: CYP2D6 Polymorphism and Metoprolol Metabolism
Metoprolol is mainly metabolized by the CYP2D6 enzyme. People with poor CYP2D6 metabolism (due to genetics or drug interactions) have higher metoprolol levels, leading to a greater reduction in heart rate and a higher risk of bradycardia. Studies consistently show that poor metabolizers experience a larger drop in heart rate (about 3 beats per minute more) and up to a fourfold increase in bradycardia risk compared to those with normal metabolismCollett2023Meloche2020. This highlights the importance of considering genetic testing or careful dose adjustments for patients at risk.
Drug Interactions: Antidepressants and Metoprolol
Some antidepressants, such as paroxetine and fluoxetine, inhibit CYP2D6 and can increase metoprolol levels. While experimental studies and case reports suggest this combination can lead to bradycardia and other side effects, large population studies have found mixed results. Most evidence suggests that the risk of bradycardia is not significantly higher when these antidepressants are used with metoprolol compared to other antidepressants, but caution and monitoring are still advisedKurdyak2012Bahar2018.
Comparison with Other Beta-Blockers and Rate-Control Agents
When compared to carvedilol, metoprolol is associated with a higher risk of emergent bradycardia, although the overall incidence remains low in routine practice. In patients with heart failure and atrial fibrillation, metoprolol is more likely to cause bradycardia and dose reductions than some other beta-blockers, such as bucindolol.
For acute atrial fibrillation with rapid ventricular rate, studies comparing metoprolol and diltiazem show that both drugs have similar rates of bradycardia. The overall risk of bradycardia is low and not significantly different between the two medications, though diltiazem may have a slightly higher rate of adverse events overallHintze2023Hintze2024.
Special Considerations: Animal Studies and Non-Pharmacological Interventions
Animal studies indicate that metoprolol can enhance the bradycardic effects of interventions like vagal nerve stimulation, but the risk of severe bradycardia remains manageable.
Conclusion
Metoprolol effectively lowers heart rate but carries a risk of bradycardia, especially in women, individuals with poor CYP2D6 metabolism, and those with certain drug interactions. While the overall risk is low, careful monitoring and individualized dosing—considering sex, genetics, and potential drug interactions—can help minimize adverse effects. In clinical practice, metoprolol’s risk of bradycardia is comparable to or slightly higher than some alternatives, but remains manageable with appropriate precautionsHendriksen2022Abraham2021Kurdyak2012+7 MORE.
Sources and full results
Most relevant research papers on this topic